How the endocannabinoid system may drive fibromyalgia symptoms
A review of emerging evidence suggests that dysregulation of the endocannabinoid system may contribute to the widespread pain, fatigue, and cognitive difficulties characteristic of fibromyalgia.
Quick Facts
What This Study Found
The endocannabinoid system plays a central role in pain perception, mood regulation, and inflammation, and variations in endocannabinoid levels and receptor activity in fibromyalgia patients may contribute to clinical symptoms.
Key Numbers
No specific numerical outcomes reported; this is a qualitative synthesis of existing literature.
How They Did This
Narrative review analyzing published literature on the endocannabinoid system's involvement in fibromyalgia pathophysiology, with a focus on pain modulation mechanisms.
Why This Research Matters
Fibromyalgia affects millions and remains poorly understood with limited treatment options. If endocannabinoid system dysfunction is a key driver, it could open pathways for targeted cannabinoid-based therapies.
The Bigger Picture
The "clinical endocannabinoid deficiency" hypothesis has been proposed as an explanation for fibromyalgia, migraines, and irritable bowel syndrome. This review gathers the evidence supporting that theory for fibromyalgia.
What This Study Doesn't Tell Us
Narrative review rather than systematic review, so subject to selection bias. Much of the evidence on ECS dysfunction in fibromyalgia is indirect or from small studies.
Questions This Raises
- ?Can endocannabinoid levels serve as biomarkers for fibromyalgia diagnosis or treatment response?
- ?Would cannabinoid therapies targeting specific ECS components outperform current fibromyalgia treatments?
Trust & Context
- Key Stat:
- proposed as a key mechanism underlying fibromyalgia pain, fatigue, and cognitive symptoms
- Evidence Grade:
- Narrative review synthesizing mostly preliminary evidence from small studies and indirect observations.
- Study Age:
- 2025 publication.
- Original Title:
- Role of the Endocannabinoid System in Fibromyalgia.
- Published In:
- Current issues in molecular biology, 47(4) (2025)
- Authors:
- García-Domínguez, Mario
- Database ID:
- RTHC-06505
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
What is the endocannabinoid deficiency theory?
The theory proposes that some chronic conditions like fibromyalgia, migraines, and IBS may result from insufficient endocannabinoid signaling. If the body does not produce enough endocannabinoids or has altered receptor function, pain and other symptoms may become amplified.
Does this mean cannabis treats fibromyalgia?
The review examines mechanisms, not treatment outcomes. Clinical trials are needed to test specific interventions.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06505APA
García-Domínguez, Mario. (2025). Role of the Endocannabinoid System in Fibromyalgia.. Current issues in molecular biology, 47(4). https://doi.org/10.3390/cimb47040230
MLA
García-Domínguez, Mario. "Role of the Endocannabinoid System in Fibromyalgia.." Current issues in molecular biology, 2025. https://doi.org/10.3390/cimb47040230
RethinkTHC
RethinkTHC Research Database. "Role of the Endocannabinoid System in Fibromyalgia." RTHC-06505. Retrieved from https://rethinkthc.com/research/garcia-dominguez-2025-role-of-the-endocannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.